Search for: "Wyeth Pharmaceuticals" Results 41 - 60 of 978
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2007, 3:03 am
Teva/IVAX may have lost on Lexapro, but Friday's a brand new day and stock traders are already looking to Teva's chances on launching a generic version of Wyeth's Protonix.AP reported on Friday, Sept. 7: Teva Pharmaceutical Industries Ltd. shares edged higher Friday as investors wondered if the company will soon launch a generic version of Wyeth's Protonix.On Thursday, a U.S. [read post]
9 Jun 2009, 9:54 am by LaBovick Law
 Pharma giant,  Wyeth - poised to be bought out by large pharmaceutical company Pfizer, Inc. later this year - is being accused of overcharging state Medicaid programs by failing to offer them the best price possible for the stomach acid drug Protonix. [read post]
17 Apr 2007, 8:58 pm
By Sherri Oslick -- In a recent press release, ARIAD Pharmaceuticals, Inc. announced that it has filed suit against Amgen Inc., certain Amgen affiliates, and Wyeth for infringement of U.S. [read post]
26 Jan 2009, 12:47 am
By MATTHEW KARNITSCHNIGPfizer Inc. on Monday agreed to pay $68 billion to acquire rival Wyeth, in the largest pharmaceutical deal in nearly a decade.Separately, Pfizer said fourth-quarter net income plunged 90% on $2.3 billion in litigation charges and that it would cut a further 10% of its work force, while Wyeth also reported a decline in fourth-quarter net profit.Pfizer is in talks to acquire rival drug maker Wyeth in a deal the could be valued at more than $60… [read post]
11 May 2010, 9:06 pm by Ed Wallis
Generic manufacturers of metoclopramide including Teva Pharmaceuticals and Actavis Elizabeth. [read post]
2 May 2010, 9:52 pm by Patent Docs
Watson Pharmaceuticals, Inc. et al. 0:10-cv-60674; filed April 29, 2010 in the Southern District of Florida • Plaintiffs: Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc. [read post]
27 Mar 2009, 8:56 am
Supreme Court ruled against a pharmaceutical manufacturer, stating that federal approval of prescription drugs does not prevent lawsuits from injured patients. [read post]
26 Jan 2009, 12:48 am
Pfizer Agrees to Pay $68 Billion for Rival Wyeth By ANDREW ROSS SORKIN and DUFF WILSON NY TIMESThe board of Pfizer, the world's largest drug maker, agreed to acquire a rival, Wyeth, for $68 billion, the companies announced Monday. [read post]
11 Mar 2009, 3:58 am
The Legal Times (3/9, Mauro) reported, "Last week's decisive Supreme Court ruling against Wyeth in a landmark pharmaceutical product liability case may also close off a major front in a hard-fought battle by businesses and the Bush administration to insulate national corporations from state tort litigation. [read post]
11 Oct 2007, 7:04 am
Yesterday, a Nevada jury hit Wyeth Pharmaceuticals with a $134.5 million verdict in a three-plaintiff hormone replacement therapy case. [read post]
14 Oct 2009, 6:26 am
"The Commission's statement noted that the transaction involved the combination of the largest prescription pharmaceutical company in both the United States and the world (Pfizer) and the twelfth-largest prescription pharmaceutical company in the United States (Wyeth). [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
24 Nov 2009, 3:30 pm
The lawyers in these cases belong to a small legal fraternity who earn their livings suing pharmaceutical companies. [read post]
13 Dec 2011, 12:25 pm by Greg Blankinship
 While there may be some reasonable market forces at play, American consumers have the right to expect that pharmaceutical companies are not manipulating the market for life-changing drugs just so they can enhance their bottom line. [read post]
31 Jul 2009, 9:55 pm
The conference will allow attendees to: • See how a new global legal paradigm for pharmaceutical patent life cycles is being shaped by forces in the U.S. and abroad; • Understand the interplay between Patent Reform and Follow-on Biologics legislation and how these pending laws will dramatically alter pharmaceutical patent life cycle strategies; •… [read post]
26 Nov 2010, 4:59 am by Carey, Danis & Lowe, L.L.C.
On November 7, federal courts judge Jayne Jagot dismissed the challenge filed by Sigma Pharmaceuticals, Generic Health Ltd. and Alphapharm Ltd. [read post]